Maeda and colleagues established of a 293-based cell line stably maintaining the HSV genome. This cell line enables efficiently producing HSV amplicon vectors without purification or transfection of the HSV genome. This system offers a more practical platform for HSV-based gene delivery, overcoming several limitations associated with conventional methods.